Findings from the HELEN-006 trial suggest a potential shift in neoadjuvant treatment practices for patients with HER2-positive early breast cancer, specifically using nab-paclitaxel to reduce ...
In the US, there was a 7.6% increase in the price of cancer drugs at 5 years post-launch and an 18.1% increase at 10 years, after adjusting for inflation. Prices of cancer drugs increase ...
To run the US Centers for Disease Control and Prevention, Trump has turned to David Weldon, MD, a long-time internist who interrupted his medical career to represent a Florida district for 7 terms in ...
"In a country with the wealth and resources of the USA, it is intolerable that so many are living in conditions and with health outcomes akin to those of an entirely different country," the ...
Clinical factors associated with an increased risk of psychological distress included younger age, female sex, advanced pathological/tumor stage, and preoperative setting.
The approval is supported by data from the COBLT study, FDA dockets and public information, and an observational database. The US Food and Drug Administration (FDA) has approved the biologics ...
The prevalence of brain metastasis was higher in non-Hispanic patients than in Hispanic patients. A retrospective study revealed differences in metastasis patterns and treatment utilization by ...